Celgene Corp.
Cancer drug maker announces senior management transition plan
Published in Oncology Business Week, January 29th, 2006
Jackson will continue as chairman of the board of directors and stand for re-election at the company's annual meeting on June 15, 2006. On May 1, Sol J. Barer will assume responsibility as the company's CEO. At the same time, Robert J. Hugin will assume Barer's current role as president and chief operating officer.
Jackson has served as chairman and CEO of Celgene since January 1996. His 10-year tenure has been marked by a dramatic strengthening of the company's financial, commercial and research operations that has transformed Celgene into a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Antisoma
Cancer drug developer sums up pipeline progress - AstraZeneca
Biotechnology company acquisition will enhance AstraZeneca's ability to generate cancer treatments - Baxter International, Inc.
Cancer medical device maker gives support to 100,000 Lives Campaign - Cephalon, Inc.
High response rates reported in use of single agent Treanda in non-Hodgkin lymphoma - EntreMed, Inc.
Pharmaceutical company to acquire Miikana Therapeutics - EpiCept Corp.
Drugmaker completes merger with Maxim Pharmaceuticals - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
